Linked Life Data

20729909

Source:http://linkedlifedata.com/resource/pubmed/id/20729909

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
43
pubmed:dateCreated
2010-10-28
pubmed:abstractText
In this issue, Weber and coworkers report that DNA-demethylating drugs alter the transcriptional expression of the cMet proto-oncogene. Abnormal transcription is driven by the antisense promoter of a Line-1 repetitive element present within an intron. The element is a recent addition to the genome and is absent in animal models of cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1476-5594
pubmed:author
pubmed:issnType
Electronic
pubmed:day
28
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5772-4
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
As we bring demethylating drugs to the clinic, we better know the DICE being cast.
pubmed:affiliation
Department of Pathology, Interdepartmental Computational Biology & Bioinformatics Program, Yale University School of Medicine, New Haven, CT 06520, USA. paul.lizardi@mac.com
pubmed:publicationType
Journal Article, Comment